To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes.

Bill Number

H.R. 8432

Origin Chamber

House

Congress

119th Congress, Session 2

Policy Area

Health

Status

Introduced

Latest Action

2026-04-22: Referred to the House Committee on Energy and Commerce.

Last Updated

2026-04-28T15:22:30Z

AI-Generated Summary

H.R. 8432: Summary

Purpose

This bill aims to strengthen the Food and Drug Administration's (FDA) ability to regulate human foods (everyday foods for people), boost research on food safety, nutrition, and innovation, and support related activities through new tools, committees, grants, and partnerships.

Key Provisions

• Sense of Congress on Innovation Funding (Sec. 2): Expresses support for a "Human Foods Innovation Account" to fund FDA projects like research grants, centers of excellence, standards development, nutrition advances, dietary supplements, biotechnology, chemical regulations, and hiring.
• Advisory Committee on Human Foods (Sec. 3): Creates a permanent FDA advisory committee of experts in nutrition, food safety, and representatives from consumer, producer, and health groups to advise on food science, nutrition, and safety.
• Critical Research Grants (Sec. 4): Directs FDA and the National Institutes of Health (NIH) to award competitive grants to nonprofits for research on topics like food biotechnology, healthier food access, infant nutrition, ultra-processed foods' health effects, specialty foods (e.g., infant formula), dietary supplements, and public education on food risks/benefits. Prioritizes collaborative projects.
• Center of Excellence (Sec. 5): Establishes a joint FDA center linking the Human Foods Program and Center for Drug Evaluation and Research to advance "food-as-medicine" research, covering weight loss drugs, food allergies, nutrition with meds/physical activity, and programs like produce prescriptions.
• Paperwork Exemption (Sec. 6): Exempts FDA's voluntary research information collections from the Paperwork Reduction Act (a law limiting federal paperwork burdens).
• Processed Food Recordkeeping (Sec. 7): Requires food companies (excluding farms and restaurants) to provide FDA access to processed food recipes, including unlabeled ingredients, amounts, and authorizations upon request; mandates submission and public website listing of non-labeled contents like flavors, colors, and additives.
• Public-Private Partnership (Sec. 8): Requires FDA to partner with nongovernmental groups for sharing data on food packaging and recommending chemical limits in foods and packaging; mandates reports to Congress starting 18 months after setup.

Significant Changes to Existing Law

• FD&C Act Amendments (Sec. 7): Expands Section 414(a) to include processed food recipes and non-labeled ingredients in recordkeeping requirements, with public disclosure of certain contents—previously focused more on traceability for outbreaks.
• Paperwork Reduction Act Exemption (Sec. 6): New carve-out allows FDA freer research data collection without standard federal paperwork approvals.

Potential Impacts

• Government Agencies: Enhances FDA and NIH capacity for research, regulation, and collaboration; suggests funding streams but does not appropriate money.
• Citizens: Could lead to safer foods, better nutrition info, and innovations like improved infant formula or allergy treatments; increases transparency on hidden food ingredients.
• Food Industry: Imposes new recordkeeping and disclosure burdens on processors, potentially raising compliance costs but fostering innovation.
• No direct international relations impacts noted.

Main Stakeholders Affected

• FDA and HHS/NIH: Gain authorities, committees, grants, and partnerships.
• Food Manufacturers/Processors: Face expanded recordkeeping and disclosure (farms/restaurants exempt).
• Researchers/Academia/Nonprofits: Eligible for grants and partnerships.
• Consumers and Health Professionals: Benefit from research, advice, and transparency.
• Industry, Consumer Groups: Involved in advisory committee and partnerships.

Notable Legal, Constitutional, or Political Implications

• Expanded FDA Authority: Increases inspection and disclosure powers without new enforcement penalties, potentially aiding recalls/outbreaks but raising industry privacy concerns.
• Non-Binding Elements: "Sense of Congress" on funding is advisory, not mandatory appropriations.
• Public-Private Ties: Promotes collaboration, which could speed innovation but requires oversight to avoid conflicts.
• No constitutional challenges evident; aligns with FDA's existing food safety mandate under the Federal Food, Drug, and Cosmetic Act.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. DeGette, Diana [D-CO-1]

Recent Actions

• 2026-04-22: Referred to the House Committee on Energy and Commerce.
• 2026-04-22: Introduced in House
• 2026-04-22: Introduced in House

Bill Versions

• To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes. — issued 2026-04-22 — PDF (9 pages)